AU3225693A - Process and uses for 4,5-dihydrogeldanamycin and its hydroquinone - Google Patents

Process and uses for 4,5-dihydrogeldanamycin and its hydroquinone

Info

Publication number
AU3225693A
AU3225693A AU32256/93A AU3225693A AU3225693A AU 3225693 A AU3225693 A AU 3225693A AU 32256/93 A AU32256/93 A AU 32256/93A AU 3225693 A AU3225693 A AU 3225693A AU 3225693 A AU3225693 A AU 3225693A
Authority
AU
Australia
Prior art keywords
compound
mammalian subject
formula
treating
proliferative disorder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU32256/93A
Other languages
English (en)
Inventor
Walter P Cullen
Mark T Jefferson
Mikel P Moyer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of AU3225693A publication Critical patent/AU3225693A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/04—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D225/06—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
AU32256/93A 1992-01-06 1992-12-03 Process and uses for 4,5-dihydrogeldanamycin and its hydroquinone Abandoned AU3225693A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81723592A 1992-01-06 1992-01-06
US817235 1992-01-06

Publications (1)

Publication Number Publication Date
AU3225693A true AU3225693A (en) 1993-08-03

Family

ID=25222638

Family Applications (1)

Application Number Title Priority Date Filing Date
AU32256/93A Abandoned AU3225693A (en) 1992-01-06 1992-12-03 Process and uses for 4,5-dihydrogeldanamycin and its hydroquinone

Country Status (15)

Country Link
JP (1) JPH06510913A (fr)
KR (1) KR940703923A (fr)
CN (1) CN1074937A (fr)
AU (1) AU3225693A (fr)
BR (1) BR9207024A (fr)
CA (1) CA2127457A1 (fr)
CZ (1) CZ390592A3 (fr)
FI (1) FI943207A (fr)
HU (1) HU9401936D0 (fr)
IL (1) IL104289A0 (fr)
MX (1) MX9300011A (fr)
NO (1) NO942532L (fr)
PT (1) PT101169A (fr)
WO (1) WO1993014215A1 (fr)
ZA (1) ZA9333B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2794342B2 (ja) * 1993-06-29 1998-09-03 ファイザー・インク． 抗癌遺伝子剤および抗癌剤としてのアンサマイシン誘導体
US5932566A (en) * 1994-06-16 1999-08-03 Pfizer Inc. Ansamycin derivatives as antioncogene and anticancer agents
US6852496B1 (en) 1997-08-12 2005-02-08 Oregon Health And Science University Methods of screening for agents that promote nerve cell growth
US6872715B2 (en) * 2001-08-06 2005-03-29 Kosan Biosciences, Inc. Benzoquinone ansamycins
KR20040054692A (ko) 2001-09-24 2004-06-25 콘포마 세러퓨틱스 코포레이션 17-알릴 아미노 겔다나마이신 (17-ａａｇ) 및 기타안사마이신의 제조 방법
EP1923061A1 (fr) 2001-09-24 2008-05-21 Conforma Therapeutic Corporation Procédé pour la préparation de 17-allyl amino geldanamycine (17-AAG) et autres ansamycines
US7465718B2 (en) 2002-02-08 2008-12-16 Conforma Therapeutics Corporation Ansamycins having improved pharmacological and biological properties
TW200303363A (en) * 2002-02-25 2003-09-01 Upjohn Co Process to prepare and isolate geldanamycin
WO2005009345A2 (fr) 2003-06-13 2005-02-03 Kosan Biosciences, Inc. Composes de 2-desmethyl ansamycine
US6887993B1 (en) 2003-11-12 2005-05-03 Kosan Biosciences, Inc. 11-O-methylgeldanamycin compounds
US6875863B1 (en) 2003-11-12 2005-04-05 Kosan Biosciences, Inc. 11-O-methylgeldanamycin compounds
US6855705B1 (en) 2003-11-12 2005-02-15 Kosan Biosciences, Inc. 11-O-methylgeldanamycin compounds
EP1682514A4 (fr) 2003-11-12 2008-07-16 Kosan Biosciences Inc Composes 11-o-methylgeldanamycine
EP1689436A1 (fr) * 2003-11-26 2006-08-16 Entelos, Inc. TRAITEMENT DE LA POLYARTHRITE RHUMATOIDE AU MOYEN D'ANTAGONISTES DU FACTEUR a INDUCTIBLE PAR HYPOXIE
US7282493B2 (en) * 2003-12-23 2007-10-16 Infinity Pharmaceuticals, Inc. Analogs of benzoquinone-containing ansamycins and methods of use thereof
ZA200604863B (en) * 2003-12-23 2007-12-27 Infinity Pharmaceuticals Inc Analogs of benzoquinone-containing ansamycins for the treatment of cancer
US20060019941A1 (en) * 2003-12-23 2006-01-26 Infinity Pharmaceuticals, Inc. Analogs of benzoquinone-containing ansamycins and methods of use thereof
NZ561939A (en) 2005-03-30 2011-03-31 Conforma Therapeutics Corp Alkynyl pyrrolopyrimidines and related analogs as HSP90-inhibitors
ES2389740T3 (es) * 2006-11-09 2012-10-31 Bristol-Myers Squibb Company Nuevos compuestos y procedimientos para su producción
PE20081506A1 (es) 2006-12-12 2008-12-09 Infinity Discovery Inc Formulaciones de ansamicina
CN100500668C (zh) * 2006-12-19 2009-06-17 中国人民解放军军事医学科学院毒物药物研究所 格尔德霉素衍生物及其制备方法和制备药物的用途
EP2121957A4 (fr) 2007-01-26 2010-11-10 Kosan Biosciences Inc Macrolactames obtenus par biosynthèse modifiée
US20110034686A1 (en) * 2008-04-21 2011-02-10 Nitin Sopanrao Patil Process for Isolation and Purification of Geldanamycin
CN102245021B (zh) 2008-10-15 2014-09-17 无限药品公司 安莎霉素氢醌组合物
CN102030764B (zh) * 2010-11-12 2012-07-04 中国医学科学院医药生物技术研究所 4，5双氢噻嗪酮格尔德霉素及其制备方法
CN103305563B (zh) * 2013-06-14 2014-12-03 湖南农业大学 一种以链霉菌提制阿里沙霉素的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3595955A (en) * 1969-03-26 1971-07-27 Upjohn Co Geldanamycin and process for producing same

Also Published As

Publication number Publication date
FI943207A0 (fi) 1994-07-05
KR940703923A (ko) 1994-12-12
PT101169A (pt) 1994-03-31
MX9300011A (es) 1993-12-01
FI943207A (fi) 1994-07-05
NO942532D0 (no) 1994-07-05
CA2127457A1 (fr) 1993-07-22
HU9401936D0 (en) 1994-09-28
BR9207024A (pt) 1995-12-05
CN1074937A (zh) 1993-08-04
JPH06510913A (ja) 1994-12-08
ZA9333B (en) 1994-07-05
CZ390592A3 (en) 1993-08-11
IL104289A0 (en) 1993-05-13
NO942532L (no) 1994-07-05
WO1993014215A1 (fr) 1993-07-22

Similar Documents

Publication Publication Date Title
AU3225693A (en) Process and uses for 4,5-dihydrogeldanamycin and its hydroquinone
US4981792A (en) Immunosuppressant compound
EP0349061B1 (fr) Agent immuno-suppresseur
US3897306A (en) 7-Hydroxy-delta 8-tetrahydrocannabinols and microbiological production thereof
JPH0320279A (ja) 新規免疫抑制剤
EP0185456B1 (fr) Composés antibiotiques/antitumoraux CL-1577D et CL-1577E, leur obtention et leur emploi
EP0182152A2 (fr) Antibiotiques antitumoraux (complexe LL-E33288)
EP0161849A2 (fr) Composés antibiotiques-antitumoraux CL-1724, les compositions pharmaceutiques les contenant et un micro-organisme producteur desdits composés
EP0087021B1 (fr) Composés antibiotiques CL 1565 et leur préparation
US4578383A (en) CL 1565 antibiotic compounds
US5494820A (en) Streptomyces braegensis strain and its cultivation in a process for producing C9 -desoxo-FK-520
KR100446323B1 (ko) Ｇｍ-95 물질, 이의 제조 방법 및 용도
US5756536A (en) Microbial transformation of taxol and cephalomannine
EP0066400A1 (fr) L'antibiotique roridine L-2 et sa préparation
US6090610A (en) Macrolide compound 0406
AU616946B2 (en) Antibacterial and antitumor agents ll-e33288epsilon-i and ll-e33288-epsilonbr, with processes and intermediates for producing said agents
US4908316A (en) Streptomyces sp. N664-30 which produces an ionophore antibacterial agent
US4751317A (en) Inophore antibacterial agent from streptomyces
EP0094176B1 (fr) Antibiotiques macrolides à partir de streptomyces
EP0855402B1 (fr) Composé terpénique 0406TP-1
US4450237A (en) Streptomyces albus subspecies indicus
JPH0639480B2 (ja) 新規マクロライド系抗生物質ｍ１１９
EP0378320A2 (fr) Produit de transformation microbienne
JPS62270527A (ja) ４１８１−２物質及びその誘導体を有効成分とする抗腫瘍剤
EP0657467A1 (fr) Antibiotiques antitumoraux